- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02059109
Evaluation of a Training Model for the Proficient Use of the Belmont Rapid Infuser
The Belmont Rapid Infuser is a device currently approved to replace larger volumes of necessary fluids such as blood in a fast and safe manner. The purpose of the study is to evaluate proficiency and the retention of knowledge of how to use the device based on current methods of training compared to revised training methods.
Hypotheses:
- The use of the traditional method of training is not effective, predicting less then half of staff will pass on the first attempt.
- Restructured test with hands-on training as opposed to oral presentation only with a written test will result in a pass rate of > 80%.
- Staff members who work in pairs will perform better than working alone when setting up the Belmont Rapid Infuser (BRI).
- Retention at 3 months will be higher with the restructured training method than with the traditional training method.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be recruited to complete a test after undergoing either the traditional or the restructured training method. This training will be completed on one day and takes about 1 hour.
All participants who pass via either method of training are evaluated again to test retention 3-4 months later .
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229-3039
- Cincinnati Children's Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants will be recruited from the faculty, Certified Registered Nurse Anesthetists, and fellows from the Department of Anesthesia at Cincinnati Children's Hospital Medical Center.
- They may have had educational exposure or use of the Belmont Rapid Infuser without independent assembly.
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Single
Staff will work alone to assemble the Belmont Rapid Infuser
|
Participants will work individually or in pairs to assemble the Belmont Rapid Infuser in addition to completing the traditional training methods.
|
|
Experimental: Pair
Staff will work in pairs to assemble the Belmont Rapid Infuser
|
Participants will work individually or in pairs to assemble the Belmont Rapid Infuser in addition to completing the traditional training methods.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proficiency
Time Frame: Measured after the training session (approximately 1 hour).
|
The composite score of "pass-pass" on BRI assembly and on knowledge test .
|
Measured after the training session (approximately 1 hour).
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Retention of proficiency
Time Frame: 3 -4 months after delivery of the effective teaching model.
|
3 -4 months after delivery of the effective teaching model.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2011-1844
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.